agilon health (NYSE:AGL) Research Coverage Started at Sanford C. Bernstein

Sanford C. Bernstein assumed coverage on shares of agilon health (NYSE:AGL) in a research note released on Wednesday, MarketBeat.com reports. The brokerage issued a market perform rating and a $2.50 price target on the stock.

A number of other research firms also recently issued reports on AGL. William Blair downgraded shares of agilon health from an “outperform” rating to a “market perform” rating in a research report on Friday, November 8th. Bank of America cut agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price objective for the company. in a report on Wednesday, October 2nd. Stifel Nicolaus dropped their target price on agilon health from $7.00 to $2.00 and set a “hold” rating on the stock in a report on Tuesday, November 12th. Barclays reduced their price target on agilon health from $5.00 to $2.00 and set an “underweight” rating for the company in a research report on Monday, November 11th. Finally, Royal Bank of Canada restated an “outperform” rating and issued a $3.00 price objective on shares of agilon health in a research report on Tuesday, November 19th. Three research analysts have rated the stock with a sell rating, fifteen have issued a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, agilon health presently has an average rating of “Hold” and an average price target of $4.38.

agilon health Trading Up 1.4 %

Shares of NYSE:AGL opened at $2.25 on Wednesday. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. agilon health has a 52-week low of $1.50 and a 52-week high of $13.76. The stock has a market cap of $927.05 million, a price-to-earnings ratio of -2.39 and a beta of 0.51. The business has a 50-day moving average price of $2.44 and a 200-day moving average price of $4.40.

agilon health (NYSE:AGL) last issued its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing the consensus estimate of ($0.10) by ($0.19). agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The business had revenue of $1.45 billion during the quarter, compared to analyst estimates of $1.47 billion. During the same quarter last year, the company posted ($0.06) EPS. Equities analysts predict that agilon health will post -0.52 EPS for the current year.

Insider Activity at agilon health

In other news, Director Diana Mckenzie acquired 12,500 shares of agilon health stock in a transaction that occurred on Monday, November 25th. The stock was purchased at an average cost of $2.28 per share, with a total value of $28,500.00. Following the purchase, the director now owns 51,319 shares in the company, valued at $117,007.32. This trade represents a 32.20 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Karen Mcloughlin bought 25,000 shares of the stock in a transaction on Friday, December 13th. The shares were acquired at an average cost of $2.20 per share, for a total transaction of $55,000.00. Following the purchase, the director now owns 73,166 shares in the company, valued at $160,965.20. The trade was a 51.90 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last three months, insiders have purchased 90,000 shares of company stock valued at $198,100. 3.20% of the stock is owned by corporate insiders.

Institutional Trading of agilon health

Hedge funds have recently bought and sold shares of the business. State Street Corp boosted its holdings in shares of agilon health by 3.0% during the 3rd quarter. State Street Corp now owns 7,449,706 shares of the company’s stock worth $29,277,000 after purchasing an additional 215,733 shares during the last quarter. Geode Capital Management LLC lifted its position in agilon health by 1.2% during the third quarter. Geode Capital Management LLC now owns 6,893,517 shares of the company’s stock worth $27,097,000 after buying an additional 84,889 shares in the last quarter. Citigroup Inc. boosted its stake in agilon health by 2,251.5% during the third quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock worth $7,971,000 after buying an additional 1,941,993 shares during the last quarter. AQR Capital Management LLC grew its holdings in agilon health by 3,338.5% in the 2nd quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock valued at $8,871,000 after buying an additional 1,316,990 shares in the last quarter. Finally, Barclays PLC increased its stake in shares of agilon health by 21.2% in the 3rd quarter. Barclays PLC now owns 1,228,952 shares of the company’s stock worth $4,830,000 after acquiring an additional 214,830 shares during the last quarter.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.